ZA874123B - Variants of alpha1-antitrypsin which are useful,in particular,as kallikrein inhibitors - Google Patents

Variants of alpha1-antitrypsin which are useful,in particular,as kallikrein inhibitors

Info

Publication number
ZA874123B
ZA874123B ZA874123A ZA874123A ZA874123B ZA 874123 B ZA874123 B ZA 874123B ZA 874123 A ZA874123 A ZA 874123A ZA 874123 A ZA874123 A ZA 874123A ZA 874123 B ZA874123 B ZA 874123B
Authority
ZA
South Africa
Prior art keywords
alpha1
antitrypsin
useful
variants
kallikrein inhibitors
Prior art date
Application number
ZA874123A
Other languages
English (en)
Inventor
Jallat Sophie
Courtney Michael
Original Assignee
Transgene S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene S.A. filed Critical Transgene S.A.
Publication of ZA874123B publication Critical patent/ZA874123B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA874123A 1986-06-10 1987-06-09 Variants of alpha1-antitrypsin which are useful,in particular,as kallikrein inhibitors ZA874123B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8608386A FR2599752B1 (fr) 1986-06-10 1986-06-10 Variants de l'alpha1- antitrypsine utiles notamment comme inhibiteurs de la kallikreine

Publications (1)

Publication Number Publication Date
ZA874123B true ZA874123B (en) 1987-12-09

Family

ID=9336200

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874123A ZA874123B (en) 1986-06-10 1987-06-09 Variants of alpha1-antitrypsin which are useful,in particular,as kallikrein inhibitors

Country Status (13)

Country Link
US (1) US4973668A (fr)
EP (1) EP0253690B1 (fr)
JP (1) JP2649804B2 (fr)
KR (1) KR880000575A (fr)
AT (1) ATE92960T1 (fr)
AU (1) AU610500B2 (fr)
CA (1) CA1328706C (fr)
DE (1) DE3786961T2 (fr)
DK (1) DK173131B1 (fr)
FR (1) FR2599752B1 (fr)
IE (1) IE61060B1 (fr)
PT (1) PT85047B (fr)
ZA (1) ZA874123B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114332T1 (de) * 1989-05-13 1994-12-15 Bayer Ag Proteinaseninhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel.
JPH07504818A (ja) 1992-03-09 1995-06-01 カイロン　コーポレイション 細胞内ｐａｃｅ４およびｐａｃｅ４．１遺伝子ならびにポリペプチドに関する組成物および方法
AU7257994A (en) * 1993-07-09 1995-02-06 Michael Laskowski Novel protein inhibitors of serine proteinases (e.g. furin) derived from turkey ovomucoid third domain
AU3479495A (en) * 1994-09-30 1996-04-26 Ppl Therapeutics (Scotland) Ltd Alpha-1-antitrypsin and antithrombine-iii variants
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US20110318359A1 (en) * 2008-12-02 2011-12-29 Feener Edward P Method for reducing blood pressure using inhibitors of plasma kallikrein
AU2012267546B2 (en) 2011-06-10 2015-12-24 Ionis Pharmaceuticals, Inc. Methods for modulating kallikrein (KLKB1) expression
EP2726153B1 (fr) 2011-06-29 2018-03-28 Ionis Pharmaceuticals, Inc. Procédés de modulation de l'expression de kallicréine (klkb1)
AU2014312196C1 (en) 2013-08-28 2019-12-19 Ionis Pharmaceuticals, Inc. Modulation of prekallikrein (PKK) expression
GB201322091D0 (en) 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
EP3862362A3 (fr) 2014-05-01 2021-10-27 Ionis Pharmaceuticals, Inc. Conjugués d'oligonucléotides antisens et leur utilisation pour moduler l'expression de la pkk
EP3585808B1 (fr) 2017-02-23 2021-11-10 Preclinics Gesellschaft für präklinische Forschung mbH Serpins modifiées pour le traitement de troubles médiés par la bradykinine
WO2018183705A1 (fr) 2017-03-29 2018-10-04 Cornell University Thérapie génique à aat résistant à l'oxydation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984000560A1 (fr) * 1982-08-04 1984-02-16 Nat Res Dev Clonage moleculaire du gene du facteur ix antihemophilique humain
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
DE3585969D1 (de) * 1984-06-14 1992-06-11 Chiron Corp Protease-inhibitoren des alpha-1-antitrypsin typs mit modifizierter aktiever stelle und deren herstellung.
DE3581328D1 (de) * 1984-06-19 1991-02-21 Transgene Sa Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
CA1299120C (fr) * 1984-10-22 1992-04-21 Glenn Kawasaki COMPOSES STABLES D'ADN SERVANT A L'EXPRESSION DE L'.alpha.-1-ANTITRYPSINE
EP0430930B1 (fr) * 1985-03-15 1993-09-01 Btg International Limited Protéine facteur IX
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
AU5864086A (en) * 1985-04-22 1986-11-18 Genetics Institute Inc. High yield production of active factor ix
FR2601033B1 (fr) * 1986-07-02 1990-01-19 Transgene Sa Variants de l'alpha-antitryspine humaine glycosylee et procede pour la preparation

Also Published As

Publication number Publication date
DK285087A (da) 1987-12-11
DK285087D0 (da) 1987-06-03
AU610500B2 (en) 1991-05-23
EP0253690A1 (fr) 1988-01-20
JP2649804B2 (ja) 1997-09-03
IE871374L (en) 1987-12-10
PT85047B (pt) 1990-03-08
JPS6379899A (ja) 1988-04-09
KR880000575A (ko) 1988-03-26
EP0253690B1 (fr) 1993-08-11
CA1328706C (fr) 1994-04-19
DK173131B1 (da) 2000-01-31
ATE92960T1 (de) 1993-08-15
US4973668A (en) 1990-11-27
DE3786961D1 (de) 1993-09-16
FR2599752A1 (fr) 1987-12-11
PT85047A (fr) 1987-07-01
AU7362587A (en) 1987-12-17
DE3786961T2 (de) 1994-01-20
IE61060B1 (en) 1994-09-21
FR2599752B1 (fr) 1989-11-03

Similar Documents

Publication Publication Date Title
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
AP9200410A0 (en) Retroviral protease inhibitors.
BG106585A (en) Kinase inhibitors as therapeutic agents
ID18143A (id) Penghambat metaloprotease amina siklik tersubstitusi
GR3034197T3 (en) Inhibitors of nitric oxide biosynthesis.
ZA874123B (en) Variants of alpha1-antitrypsin which are useful,in particular,as kallikrein inhibitors
MY111370A (en) Dual action inhibitors
EA199700124A1 (ru) Производные гуанина
EP0172458A3 (en) Novel biologically active compound having anti-prolyl endopeptidase activity
BG103485A (en) Ketobanzamides as calpain inhibitors
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES2036562T3 (es) Un procedimiento para produccion de un derivado de pirrolidinamida.
NO983688L (no) Serin-protease-inhibitorer
ES8701782A1 (es) Un procedimiento para la fabricacion de derivados peptidicos inhibidores de la renina y de las proteasas acidas
NO892267D0 (no) Hirudinderivater med forsinket virkning.
BR0211826A (pt) Imidazopiridinas tricìclicas
MX9801190A (es) Inhibidores de prolil endopeptidasa.
HU9500559D0 (en) New mercapto-acetamide tricyclic derivatives as enkephalinase-inhibitors
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
CA1268468C (fr) Analogues des prostaglandines avec groupement thiabicycloheptane substitue
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
NO995132L (no) Fremgangsmåte for reduksjon av fibrinogen
MX9304351A (es) Inhibidores de proteasas de aminodiol y composiciones farmaceuticas que los incluyen.
RO87034B1 (ro) Medicament pentru tratamentul afectiunilor reumatismale